SlideShare a Scribd company logo
1 of 12
Chapter 2
Review of Basic Principles
of Pharmacology
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Introduction
Pharmacodynamics
Drug-receptor interaction
Drug-receptor activity
Dose-response relationship
Drug potency and efficacy
Pharmacokinetics
Absorption
Distribution
Metabolism
Elimination
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Pharmacodynamics
The effect of drugs on the body
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Pharmacokinetics
Absorption
Distribution
Metabolism
Excretion
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Drug-Receptor Interactions
Most drugs work by binding to receptors.
Receptors are located on the cell surface.
The drug molecule must “fit” into the receptor.
Like a lock and key mechanism
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Drug-Receptor Binding
Drug-receptor binding is reversible.
Drug-receptor binding is selective.
Drug-receptor binding is graded.
The more receptors filled, the greater the pharmacological
response.
Drugs that bind to receptors may be agonists, partial agonists,
or antagonistic.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
How Drug Dose Is Determined
Dose-response relationship
Therapeutic index
Plasma level profile
Half-life
Bioavailability
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Drug-Dose Relationship
Dose-response curve: depicts the relation between drug dose
and magnitude of effect
Doses below the curve do not produce a pharmacological
response.
Doses above the curve do not produce much additional
pharmacological response.
May have unwanted effects → toxicity
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Plasma Level Profile
Onset of action: time between administration and first sign of
drug effect
Peak of action: maximum concentration of drug
Point at which amount of drug being absorbed and distributed is
equal to amount being metabolized and excreted
Duration of action: continued entry of drug into body with
levels above minimum effective concentration
Termination of action
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Minimum Effective and Minimum Toxic Concentration
Minimum effective concentration (MEC): level below which
therapeutic effects will not occur
Minimum toxic concentration (MTC): level above which toxic
effects begin
Therapeutic index or range: MTC to MEC
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Drug Bioavailability
Percentage of drug that is absorbed and available to reach the
target tissues
By definition, when a medication is administered IV, its
bioavailability is 100%.
When a medication is administered via other routes (e.g., PO),
its bioavailability decreases due to incomplete absorption and
first-pass metabolism.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Therapeutic Blood Level
It usually takes 4 to 5 ½ lives to get to steady state blood levels.
Loading dose
It takes 4 to 5 ½ lives to totally eliminate a drug from the body.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Absorption
Definition: movement of a drug from its site of administration
into the blood
Variables that influence absorption
Nature of the cell membrane
Blood flow at site of administration
Solubility of drug
pH
Molecular weight
Drug concentration
Dosage form
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Distribution
Definition: movement of absorbed drug in bodily fluids
throughout body to target tissues
Distribution requires adequate blood supply.
Drug distributed to areas of high blood flow first
Areas of low blood flow
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Protein Binding
In circulation, drugs are bound to protein.
Some of the drug is not bound and is called free drug.
Free drug + Bound drug ⬄Drug-protein complex
Dynamic
Free drug is active drug.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Degree of Drug Binding
Drugs exist in bound and unbound states.
Travel when bound, cross membranes when unbound
“Highly” protein-bound
Ratio of bound drug usually remains stable
Low plasma proteins (low albumen) will result in more free
drug in circulation.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Competition for Protein-Binding Sites
Finite number of plasma proteins
Compete and displace each other → more free drug
Higher risk for toxicity
More drug may be eliminated
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Tissue Distribution
Fat
Lipid-soluble fats have a high affinity for adipose tissue.
Adipose tissue has low blood flow.
Bone
Some drugs have affinity for bone.
For example, tetracyclines deposit in bones and teeth.
Blood-brain barrier
The blood-brain barrier is relatively impenetrable.
Usually protective
Only lipid-soluble drugs cross barrier.
Placental barrier
Many drugs pass barrier.
Low molecular weight drugs pass easier.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Metabolism
AKA: biotransformation
Definition: chemical change of drug structure to:
1. Enhance excretion
2. Inactivate the drug
3. Increase therapeutic action
4. Activate a prodrug
5. Increase or decrease toxicity
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Factors That Influence Metabolism
Age
Genetically determined differences
Pregnancy
Liver disease
Time of day
Environment
Diet
Alcohol
Drug interactions
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Factors That Influence Metabolism (cont’d)
Drugs undergo one or both of two types of chemical reactions in
the liver:
Phase I: oxidation, hydrolysis, or reduction to increase water
solubility of drug molecules
Phase II: conjugation or union of drug molecule with water-
soluble substance
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Phase I Enzymes:
Cytochrome P450 Isoenzymes
The majority of drugs are metabolized in the liver by the
hepatic isoenzymes.
Cytochrome P450 isoenzymes
CYP 450
Most common
1A2, 2C9, 2C19, 2D6, 3A4 (3A3/4)
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
CYP 450 Enzymes
There are developmental differences in the isoenzymes.
There are genetic differences in isoenzymes.
Some disease states alter isoenzyme activity.
For example, cystic fibrosis has altered
CYP 2D9 activity.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Phase I Enzymes: CYP 450
The enzymes may be slowed (inhibited) or increased (induced).
Concurrent therapy with an inhibitor or inducer may alter the
metabolism of a medication.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Prodrug Metabolism
A prodrug is a drug which is administered in an inactive (or
significantly less active) form.
Once administered, the prodrug is metabolized in the body into
the active compound.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Elimination
AKA: excretion
Definition: removal of the drug from the body by organs of
elimination
Most drugs are eliminated by the kidneys.
Drugs are also eliminated by
Lungs
Gastrointestinal (GI) tract
Sweat and saliva
Mammary glands (breast milk)
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Renal Elimination
Passive glomerular filtration
Active tubular secretion
Tubular reabsorption
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Glomerular Filtration
The availability of the drug for glomerular filtration
Drug must be unbound from protein
Free-, unbound, and water-soluble metabolites are filtered by
the glomeruli.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Factors That Affect Renal Excretion
Kidney function
Age
Hydration
Cardiac output
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
GI Tract Excretion
Biliary excretion
After being metabolized in the liver, the metabolite is excreted
into the bile.
Some drugs may then be reabsorbed in the intestine.
Enterohepatic cycle
Fecal excretion
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Lung Excretion
Gases
General anesthetics and volatile liquids
Rate of excretion is based on respiratory rate and pulmonary
blood flow.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Sweat/Salivary Excretion
Not very many drugs
Excretion in sweat may be a cause of adverse effects, such as a
rash (dermatitis).
Salivary excretion
May be the reason patients complain of “taste” in their mouth
with certain drugs
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Mammary Excretion
Many drugs are excreted in breast milk.
Smaller molecular weight
Lipid soluble
Breast milk is acidic.
Pharmacotherapeutics for Advanced Nurse Practitioner
Prescribers, 4th Edition
Copyright © 2016 F.A. Davis Company
Chapter 2Review of Basic Principles of Pharmacology .docx

More Related Content

Similar to Chapter 2Review of Basic Principles of Pharmacology .docx

Biopharmaceutics
BiopharmaceuticsBiopharmaceutics
BiopharmaceuticsSa Na
 
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023   BAA.pptxBasic Princioles of Pharmacokinetics 05 02 2023   BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptxmaamedokuah233
 
Orientation To Pharmacology
Orientation To PharmacologyOrientation To Pharmacology
Orientation To PharmacologyTpetrici
 
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)Kamruzzaman Siam
 
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)Kamruzzaman Siam
 
Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlespooranachithra flowry
 
introduction to biopharmaceutics
introduction to biopharmaceutics introduction to biopharmaceutics
introduction to biopharmaceutics Tehmina Adnan
 
introductionofpharmacology-141126031620-conversion-gate01.ppt
introductionofpharmacology-141126031620-conversion-gate01.pptintroductionofpharmacology-141126031620-conversion-gate01.ppt
introductionofpharmacology-141126031620-conversion-gate01.pptjuuisha
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsUniversity of Miami
 
bioavailability & bioequivalence
bioavailability & bioequivalence bioavailability & bioequivalence
bioavailability & bioequivalence BINDIYA PATEL
 
Introduction of Veterinary pharmacology
Introduction of Veterinary  pharmacologyIntroduction of Veterinary  pharmacology
Introduction of Veterinary pharmacologyQaline Giigii
 
Introduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi Farah
Introduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi FarahIntroduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi Farah
Introduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi FarahQaline Giigii
 
Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...Nani Karnam Vinayakam
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsUniversity of Miami
 
Pharmacokinetics (1).ppt
Pharmacokinetics (1).pptPharmacokinetics (1).ppt
Pharmacokinetics (1).pptssuser497f37
 

Similar to Chapter 2Review of Basic Principles of Pharmacology .docx (20)

Biopharmaceutics
BiopharmaceuticsBiopharmaceutics
Biopharmaceutics
 
SRDDS (1).pptx
SRDDS (1).pptxSRDDS (1).pptx
SRDDS (1).pptx
 
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023   BAA.pptxBasic Princioles of Pharmacokinetics 05 02 2023   BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
 
Orientation To Pharmacology
Orientation To PharmacologyOrientation To Pharmacology
Orientation To Pharmacology
 
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
 
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Introduction to clinical pharmacy
Introduction to clinical pharmacyIntroduction to clinical pharmacy
Introduction to clinical pharmacy
 
Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principles
 
introduction to biopharmaceutics
introduction to biopharmaceutics introduction to biopharmaceutics
introduction to biopharmaceutics
 
Pharmacokinitic
PharmacokiniticPharmacokinitic
Pharmacokinitic
 
introductionofpharmacology-141126031620-conversion-gate01.ppt
introductionofpharmacology-141126031620-conversion-gate01.pptintroductionofpharmacology-141126031620-conversion-gate01.ppt
introductionofpharmacology-141126031620-conversion-gate01.ppt
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokinetics
 
bioavailability & bioequivalence
bioavailability & bioequivalence bioavailability & bioequivalence
bioavailability & bioequivalence
 
Pharmacology
Pharmacology  Pharmacology
Pharmacology
 
Introduction of Veterinary pharmacology
Introduction of Veterinary  pharmacologyIntroduction of Veterinary  pharmacology
Introduction of Veterinary pharmacology
 
Introduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi Farah
Introduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi FarahIntroduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi Farah
Introduction of Veterinary pharmacology Somaliland Dr.Osman Abdulahi Farah
 
Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...Experimental and clinical validation of classical and proproetary ayurvedic f...
Experimental and clinical validation of classical and proproetary ayurvedic f...
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokinetics
 
Pharmacokinetics (1).ppt
Pharmacokinetics (1).pptPharmacokinetics (1).ppt
Pharmacokinetics (1).ppt
 

More from christinemaritza

ENG315                                    Professional Scenari.docx
ENG315                                    Professional Scenari.docxENG315                                    Professional Scenari.docx
ENG315                                    Professional Scenari.docxchristinemaritza
 
ENG122 – Research Paper Peer Review InstructionsApply each of .docx
ENG122 – Research Paper Peer Review InstructionsApply each of .docxENG122 – Research Paper Peer Review InstructionsApply each of .docx
ENG122 – Research Paper Peer Review InstructionsApply each of .docxchristinemaritza
 
ENG122 – Research Paper Peer Review InstructionsApply each of th.docx
ENG122 – Research Paper Peer Review InstructionsApply each of th.docxENG122 – Research Paper Peer Review InstructionsApply each of th.docx
ENG122 – Research Paper Peer Review InstructionsApply each of th.docxchristinemaritza
 
ENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docx
ENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docxENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docx
ENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docxchristinemaritza
 
ENG 510 Final Project Milestone Three Guidelines and Rubric .docx
ENG 510 Final Project Milestone Three Guidelines and Rubric .docxENG 510 Final Project Milestone Three Guidelines and Rubric .docx
ENG 510 Final Project Milestone Three Guidelines and Rubric .docxchristinemaritza
 
ENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docx
ENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docxENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docx
ENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docxchristinemaritza
 
ENG 272-0Objective The purpose of this essay is t.docx
ENG 272-0Objective  The purpose of this essay is t.docxENG 272-0Objective  The purpose of this essay is t.docx
ENG 272-0Objective The purpose of this essay is t.docxchristinemaritza
 
ENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docx
ENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docxENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docx
ENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docxchristinemaritza
 
ENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docx
ENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docxENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docx
ENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docxchristinemaritza
 
ENG 3107 Writing for the Professions—Business & Social Scienc.docx
ENG 3107 Writing for the Professions—Business & Social Scienc.docxENG 3107 Writing for the Professions—Business & Social Scienc.docx
ENG 3107 Writing for the Professions—Business & Social Scienc.docxchristinemaritza
 
ENG 271Plato and Aristotlea Classical Greek philosophe.docx
ENG 271Plato and Aristotlea Classical Greek philosophe.docxENG 271Plato and Aristotlea Classical Greek philosophe.docx
ENG 271Plato and Aristotlea Classical Greek philosophe.docxchristinemaritza
 
ENG 315 Professional Communication Week 4 Discussion Deliver.docx
ENG 315 Professional Communication Week 4 Discussion Deliver.docxENG 315 Professional Communication Week 4 Discussion Deliver.docx
ENG 315 Professional Communication Week 4 Discussion Deliver.docxchristinemaritza
 
ENG 315 Professional Communication Week 9Professional Exp.docx
ENG 315 Professional Communication Week 9Professional Exp.docxENG 315 Professional Communication Week 9Professional Exp.docx
ENG 315 Professional Communication Week 9Professional Exp.docxchristinemaritza
 
ENG 202 Questions about Point of View in Ursula K. Le Guin’s .docx
ENG 202 Questions about Point of View in Ursula K. Le Guin’s .docxENG 202 Questions about Point of View in Ursula K. Le Guin’s .docx
ENG 202 Questions about Point of View in Ursula K. Le Guin’s .docxchristinemaritza
 
ENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docx
ENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docxENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docx
ENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docxchristinemaritza
 
ENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docx
ENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docxENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docx
ENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docxchristinemaritza
 
ENG 130 Literature and Comp ENG 130 Argumentative Resear.docx
ENG 130 Literature and Comp ENG 130 Argumentative Resear.docxENG 130 Literature and Comp ENG 130 Argumentative Resear.docx
ENG 130 Literature and Comp ENG 130 Argumentative Resear.docxchristinemaritza
 
ENG 132What’s Wrong With HoldenHere’s What You Should Do, .docx
ENG 132What’s Wrong With HoldenHere’s What You Should Do, .docxENG 132What’s Wrong With HoldenHere’s What You Should Do, .docx
ENG 132What’s Wrong With HoldenHere’s What You Should Do, .docxchristinemaritza
 
ENG 130- Literature and Comp Literary Response for Setting.docx
ENG 130- Literature and Comp Literary Response for Setting.docxENG 130- Literature and Comp Literary Response for Setting.docx
ENG 130- Literature and Comp Literary Response for Setting.docxchristinemaritza
 
ENG 130 Literature and Comp Literary Response for Point o.docx
ENG 130 Literature and Comp Literary Response for Point o.docxENG 130 Literature and Comp Literary Response for Point o.docx
ENG 130 Literature and Comp Literary Response for Point o.docxchristinemaritza
 

More from christinemaritza (20)

ENG315                                    Professional Scenari.docx
ENG315                                    Professional Scenari.docxENG315                                    Professional Scenari.docx
ENG315                                    Professional Scenari.docx
 
ENG122 – Research Paper Peer Review InstructionsApply each of .docx
ENG122 – Research Paper Peer Review InstructionsApply each of .docxENG122 – Research Paper Peer Review InstructionsApply each of .docx
ENG122 – Research Paper Peer Review InstructionsApply each of .docx
 
ENG122 – Research Paper Peer Review InstructionsApply each of th.docx
ENG122 – Research Paper Peer Review InstructionsApply each of th.docxENG122 – Research Paper Peer Review InstructionsApply each of th.docx
ENG122 – Research Paper Peer Review InstructionsApply each of th.docx
 
ENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docx
ENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docxENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docx
ENG115ASSIGNMENT2STANCEESSAYDRAFTDueWeek.docx
 
ENG 510 Final Project Milestone Three Guidelines and Rubric .docx
ENG 510 Final Project Milestone Three Guidelines and Rubric .docxENG 510 Final Project Milestone Three Guidelines and Rubric .docx
ENG 510 Final Project Milestone Three Guidelines and Rubric .docx
 
ENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docx
ENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docxENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docx
ENG-105 Peer Review Worksheet Rhetorical Analysis of a Public.docx
 
ENG 272-0Objective The purpose of this essay is t.docx
ENG 272-0Objective  The purpose of this essay is t.docxENG 272-0Objective  The purpose of this essay is t.docx
ENG 272-0Objective The purpose of this essay is t.docx
 
ENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docx
ENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docxENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docx
ENG 360 01 American PoetrySpring 2019TuesdayFriday 800 –.docx
 
ENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docx
ENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docxENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docx
ENG 4034AHamlet Final AssessmentDUE DATE WEDNESDAY, 1220, 1.docx
 
ENG 3107 Writing for the Professions—Business & Social Scienc.docx
ENG 3107 Writing for the Professions—Business & Social Scienc.docxENG 3107 Writing for the Professions—Business & Social Scienc.docx
ENG 3107 Writing for the Professions—Business & Social Scienc.docx
 
ENG 271Plato and Aristotlea Classical Greek philosophe.docx
ENG 271Plato and Aristotlea Classical Greek philosophe.docxENG 271Plato and Aristotlea Classical Greek philosophe.docx
ENG 271Plato and Aristotlea Classical Greek philosophe.docx
 
ENG 315 Professional Communication Week 4 Discussion Deliver.docx
ENG 315 Professional Communication Week 4 Discussion Deliver.docxENG 315 Professional Communication Week 4 Discussion Deliver.docx
ENG 315 Professional Communication Week 4 Discussion Deliver.docx
 
ENG 315 Professional Communication Week 9Professional Exp.docx
ENG 315 Professional Communication Week 9Professional Exp.docxENG 315 Professional Communication Week 9Professional Exp.docx
ENG 315 Professional Communication Week 9Professional Exp.docx
 
ENG 202 Questions about Point of View in Ursula K. Le Guin’s .docx
ENG 202 Questions about Point of View in Ursula K. Le Guin’s .docxENG 202 Questions about Point of View in Ursula K. Le Guin’s .docx
ENG 202 Questions about Point of View in Ursula K. Le Guin’s .docx
 
ENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docx
ENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docxENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docx
ENG 220250 Lab Report Requirements Version 0.8 -- 0813201.docx
 
ENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docx
ENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docxENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docx
ENG 203 Short Article Response 2 Sample Answer (Worth 13 mark.docx
 
ENG 130 Literature and Comp ENG 130 Argumentative Resear.docx
ENG 130 Literature and Comp ENG 130 Argumentative Resear.docxENG 130 Literature and Comp ENG 130 Argumentative Resear.docx
ENG 130 Literature and Comp ENG 130 Argumentative Resear.docx
 
ENG 132What’s Wrong With HoldenHere’s What You Should Do, .docx
ENG 132What’s Wrong With HoldenHere’s What You Should Do, .docxENG 132What’s Wrong With HoldenHere’s What You Should Do, .docx
ENG 132What’s Wrong With HoldenHere’s What You Should Do, .docx
 
ENG 130- Literature and Comp Literary Response for Setting.docx
ENG 130- Literature and Comp Literary Response for Setting.docxENG 130- Literature and Comp Literary Response for Setting.docx
ENG 130- Literature and Comp Literary Response for Setting.docx
 
ENG 130 Literature and Comp Literary Response for Point o.docx
ENG 130 Literature and Comp Literary Response for Point o.docxENG 130 Literature and Comp Literary Response for Point o.docx
ENG 130 Literature and Comp Literary Response for Point o.docx
 

Recently uploaded

Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 

Recently uploaded (20)

Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 

Chapter 2Review of Basic Principles of Pharmacology .docx

  • 1. Chapter 2 Review of Basic Principles of Pharmacology Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Introduction Pharmacodynamics Drug-receptor interaction Drug-receptor activity Dose-response relationship Drug potency and efficacy Pharmacokinetics Absorption Distribution Metabolism Elimination Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Pharmacodynamics The effect of drugs on the body Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company
  • 2. Pharmacokinetics Absorption Distribution Metabolism Excretion Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Drug-Receptor Interactions Most drugs work by binding to receptors. Receptors are located on the cell surface. The drug molecule must “fit” into the receptor. Like a lock and key mechanism Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Drug-Receptor Binding Drug-receptor binding is reversible. Drug-receptor binding is selective. Drug-receptor binding is graded. The more receptors filled, the greater the pharmacological response. Drugs that bind to receptors may be agonists, partial agonists, or antagonistic. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company How Drug Dose Is Determined Dose-response relationship Therapeutic index
  • 3. Plasma level profile Half-life Bioavailability Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Drug-Dose Relationship Dose-response curve: depicts the relation between drug dose and magnitude of effect Doses below the curve do not produce a pharmacological response. Doses above the curve do not produce much additional pharmacological response. May have unwanted effects → toxicity Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Plasma Level Profile Onset of action: time between administration and first sign of drug effect Peak of action: maximum concentration of drug Point at which amount of drug being absorbed and distributed is equal to amount being metabolized and excreted Duration of action: continued entry of drug into body with levels above minimum effective concentration Termination of action Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Minimum Effective and Minimum Toxic Concentration
  • 4. Minimum effective concentration (MEC): level below which therapeutic effects will not occur Minimum toxic concentration (MTC): level above which toxic effects begin Therapeutic index or range: MTC to MEC Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Drug Bioavailability Percentage of drug that is absorbed and available to reach the target tissues By definition, when a medication is administered IV, its bioavailability is 100%. When a medication is administered via other routes (e.g., PO), its bioavailability decreases due to incomplete absorption and first-pass metabolism. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Therapeutic Blood Level It usually takes 4 to 5 ½ lives to get to steady state blood levels. Loading dose It takes 4 to 5 ½ lives to totally eliminate a drug from the body. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Absorption Definition: movement of a drug from its site of administration into the blood Variables that influence absorption
  • 5. Nature of the cell membrane Blood flow at site of administration Solubility of drug pH Molecular weight Drug concentration Dosage form Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Distribution Definition: movement of absorbed drug in bodily fluids throughout body to target tissues Distribution requires adequate blood supply. Drug distributed to areas of high blood flow first Areas of low blood flow Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Protein Binding In circulation, drugs are bound to protein. Some of the drug is not bound and is called free drug. Free drug + Bound drug ⬄Drug-protein complex Dynamic Free drug is active drug. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company
  • 6. Degree of Drug Binding Drugs exist in bound and unbound states. Travel when bound, cross membranes when unbound “Highly” protein-bound Ratio of bound drug usually remains stable Low plasma proteins (low albumen) will result in more free drug in circulation. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Competition for Protein-Binding Sites Finite number of plasma proteins Compete and displace each other → more free drug Higher risk for toxicity More drug may be eliminated Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Tissue Distribution Fat Lipid-soluble fats have a high affinity for adipose tissue. Adipose tissue has low blood flow. Bone Some drugs have affinity for bone. For example, tetracyclines deposit in bones and teeth. Blood-brain barrier The blood-brain barrier is relatively impenetrable. Usually protective Only lipid-soluble drugs cross barrier. Placental barrier Many drugs pass barrier. Low molecular weight drugs pass easier.
  • 7. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Metabolism AKA: biotransformation Definition: chemical change of drug structure to: 1. Enhance excretion 2. Inactivate the drug 3. Increase therapeutic action 4. Activate a prodrug 5. Increase or decrease toxicity Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Factors That Influence Metabolism Age Genetically determined differences Pregnancy Liver disease Time of day Environment Diet Alcohol Drug interactions Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Factors That Influence Metabolism (cont’d) Drugs undergo one or both of two types of chemical reactions in the liver:
  • 8. Phase I: oxidation, hydrolysis, or reduction to increase water solubility of drug molecules Phase II: conjugation or union of drug molecule with water- soluble substance Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Phase I Enzymes: Cytochrome P450 Isoenzymes The majority of drugs are metabolized in the liver by the hepatic isoenzymes. Cytochrome P450 isoenzymes CYP 450 Most common 1A2, 2C9, 2C19, 2D6, 3A4 (3A3/4) Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company CYP 450 Enzymes There are developmental differences in the isoenzymes. There are genetic differences in isoenzymes. Some disease states alter isoenzyme activity. For example, cystic fibrosis has altered CYP 2D9 activity. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Phase I Enzymes: CYP 450 The enzymes may be slowed (inhibited) or increased (induced). Concurrent therapy with an inhibitor or inducer may alter the
  • 9. metabolism of a medication. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Prodrug Metabolism A prodrug is a drug which is administered in an inactive (or significantly less active) form. Once administered, the prodrug is metabolized in the body into the active compound. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Elimination AKA: excretion Definition: removal of the drug from the body by organs of elimination Most drugs are eliminated by the kidneys. Drugs are also eliminated by Lungs Gastrointestinal (GI) tract Sweat and saliva Mammary glands (breast milk) Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Renal Elimination Passive glomerular filtration Active tubular secretion Tubular reabsorption
  • 10. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Glomerular Filtration The availability of the drug for glomerular filtration Drug must be unbound from protein Free-, unbound, and water-soluble metabolites are filtered by the glomeruli. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Factors That Affect Renal Excretion Kidney function Age Hydration Cardiac output Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company GI Tract Excretion Biliary excretion After being metabolized in the liver, the metabolite is excreted into the bile. Some drugs may then be reabsorbed in the intestine. Enterohepatic cycle Fecal excretion Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company
  • 11. Lung Excretion Gases General anesthetics and volatile liquids Rate of excretion is based on respiratory rate and pulmonary blood flow. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Sweat/Salivary Excretion Not very many drugs Excretion in sweat may be a cause of adverse effects, such as a rash (dermatitis). Salivary excretion May be the reason patients complain of “taste” in their mouth with certain drugs Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company Mammary Excretion Many drugs are excreted in breast milk. Smaller molecular weight Lipid soluble Breast milk is acidic. Pharmacotherapeutics for Advanced Nurse Practitioner Prescribers, 4th Edition Copyright © 2016 F.A. Davis Company